Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAKR: Early Factors in Type 1 Diabetes Progression
NCT02184676Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2015
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Open-label trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Autoreactive T lymphocytes at 48 months. Started May 2015; status: completed.
Beyond the preview
Go deeper on NCT02184676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184676.